Persistence And Concomitant Drug Use On Branded Desvenlafaxine Compared With Other Antidepressants In Patients With Major Depressive Disorder

To compare medication persistence and concomitant MDD drug use in patients prescribed i) branded desvenlafaxine, ii) other branded selective serotonin re-uptake inhibitors (SSRIs) and selective serotonin-norepinephrine re-uptake inhibitors (SNRIs), and iii) generic SSRIs/SNRIs (escitalopram, venlafaxine, citalopram, fluvoxamine, sertraline, fluoxetine and paroxetine).

Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: A Shelbaya, C Deshpande, E Pappadopulos, J Alvir, V Chirikov, JM Stephens Source Type: research